Journal profile · CELL & TISSUE ENGINEERING-CELL BIOLOGY
Stem Cell Reviews and Reports
ISSN 1550-8943 · eISSN 2629-3277 · Springer US · UNITED STATES · 8 issues per year · Founded 2005
Stem Cell Reviews and Reports: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.85; hybrid open access; APC about USD 4,390; median 62 days to acceptance (64 articles, last 24 months); community-reported acceptance: moderate; 208 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Stem Cell Reviews and Reports is published by Springer US and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Pluripotent Stem Cells Research and Tissue Engineering and Regenerative Medicine, together about 43.6% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The purpose of Stem Cell Reviews and Reports is to cover contemporary and emerging areas in stem cell research and regenerative medicine. The journal will consider for publication: i) solicited or unsolicited reviews of topical areas of stem cell biology that highlight, critique and synthesize recent important findings in the field ii) full length and short reports presenting original experimental work iii) translational stem cell studies describing results of clinical trials using stem cells as therapeutics iv) papers focused on diseases of stem cells v) hypothesis and commentary articles as opinion-based pieces in which authors can propose a new theory, interpretation of a controversial area in stem cell biology, or a stem cell biology question or paradigm. These articles contain more speculation than reviews, but they should be based on solid rationale. vi) protocols as peer-reviewed procedures that provide step-by-step descriptions, outlined in sufficient detail, so that both experts and novices can apply them to their own research vii) brief commentary For more detailed information including article length, online submission and more please visit our web page. In order to facilitate this exchange of scientific information and exciting novel ideas, the journal has created five thematic sections, focusing on: i) the role of adult stem cells in tissue regeneration, ii) progress in research on induced pluripotent stem cells, embryonic stem cells and mechanism governing embryogenesis and tissue development, iii) the role of microenvironment and extracellular microvesicles in directing the fate of stem cells iv) mechanisms of stem cell trafficking, stem cell mobilization and homing with special emphasis on hematopoiesis v) the role of stem cells in aging processes and cancerogenesis. Stem Cell Reviews and Reports now publishes six issues a year and will be open to new discoveries and challenging ideas. We encourage you to submit your best work so that, if accepted, it will become an immediate and important contribution to the worldwide scientific community.Founding and Previous Editors include Dr. Stewart Sell and Dr. Kursad Turksen.
From the journal's Aims & Scope
Research area (LetPub): CELL & TISSUE ENGINEERING-CELL BIOLOGY
Editor-in-chief Mariusz Z. RatajczakPublisher website
Editorial board by country: 5 in mainland China (about 9%); most named United States 22, Poland 6, Mainland China 5, Brazil 5, France 4 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine18.4%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology16.4%
- Tissue Engineering and Regenerative MedicineMedicine8.7%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology5.7%
- Cancer Cells and MetastasisMedicine4.5%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.3%
- 3D Printing in Biomedical ResearchEngineering4.1%
- Hematopoietic Stem Cell TransplantationMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.85LetPub ·
- Impact factor (publisher) 2025
- 4.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.9Publisher website ·
- CiteScore 2026-06
- 9.6LetPub ·
- SJR 2026-06
- 1.22LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 61LetPub ·
- h-index
- 111OpenAlex ·
- i10-index
- 1,417OpenAlex ·
- 2-year mean citedness
- 4.34OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 38.68%LetPub ·
Volume
- Articles per year
- 179LetPub ·
- Downloads per year (publisher) 2025
- 1,100,000Publisher website ·
Articles by year OpenAlex count · 2,364 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 195 | 51 | 68 |
| 2025 | 208 | 88 | 766 |
| 2024 | 159 | 66 | 1,606 |
| 2023 | 179 | 71 | 2,257 |
| 2022 | 188 | 89 | 3,873 |
| 2021 | 211 | 123 | 4,948 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
62 daysMedian, submission to acceptance · P25–P75 28 days – 95 days
- Acceptance to online
- median 13 days (101 articles)
- Submission to online
- median 77 days
- Sample
- 64 articles with submission and acceptance dates (447 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,690 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 10,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required, 3
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted9, with length limits
- brief reportArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…main text ≤ 5,000 words
- commentaryArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- hypothesisArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…main text ≤ 5,000 words
- opinionArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- original researchArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- perspectiveArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- protocolArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- research articleArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…Length not stated
- reviewArticle types that will be considered for publication: 1. Reviews: Solicited or unsolicited 4,000-10,000 word reviews of topical areas of stem cell biology that…main text ≤ 10,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Stem Cell Reviews and Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- 8 issues per year
- Founded
- 2005
- ISSN
- 1550-8943
- Print ISSN
- 2629-3269
- Electronic ISSN
- 2629-3277
- Latest issue on the website
- Volume 22, Issue 7 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Stem Cell Reviews and Reports
What CAS zone is Stem Cell Reviews and Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Stem Cell Reviews and Reports is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell & Tissue Engineering / Cell Biology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Stem Cell Reviews and Reports?
The latest impact factor listed by LetPub is 4.85; CiteScore 9.6, h-index 111.
How long does peer review take at Stem Cell Reviews and Reports?
Based on the dates recorded on 64 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 62 days (interquartile range 28–95 days); authors report an average review time of about 3 months; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Stem Cell Reviews and Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 10,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Required, 3; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Stem Cell Reviews and Reports based?
Of the 57 board members whose country the journal's board page names, 5 (about 9%) are in mainland China; the countries named most often are United States (22), Poland (6) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Stem Cell Reviews and Reports?
According to LetPub and DOAJ records, Stem Cell Reviews and Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Stem Cell Reviews and Reports open access, and what is the APC?
Stem Cell Reviews and Reports is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .